Results 1 - 10 of 14 for ponatinib
  1. Ponatinib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer ... cannot take these medications because of side effects. Ponatinib is also used to treat a certain type ...
  2. CML Guide: Information for Patients and Caregivers (Leukemia & Lymphoma Society) - PDF  
    ... cells used for a stem cell transplant. Iclusig® (ponatinib). A type of drug called a tyrosine kinase ...
  3. ... to use a birth control method during treatment. Ponatinib (brand name: Iclusig) — Ponatinib is another TKI that may be recommended for ... T315I). Due to concerns regarding dangerous side effects, ponatinib is reserved for use in patients who are ...
  4. Drugs Approved for Leukemia (National Cancer Institute)  
    ... Methotrexate) Folex PFS (Methotrexate) Gleevec (Imatinib Mesylate) Iclusig (Ponatinib Hydrochloride) Imatinib Mesylate Marqibo (Vincristine Sulfate Liposome) Mercaptopurine ...
  5. ... Inhibitors imatinib mesylate (Gleevec®), dasatinib (Sprycel®), nilotinib (Tasigna®), ponatinib (Iclusig®) Corticosteroids prednisone, prednisolone, dexamethasone Monoclonal Antibodies alemtuzumab ( ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... I Ibrance (Palbociclib) Ibritumomab Tiuxetan Ibrutinib ICE Iclusig (Ponatinib Hydrochloride) Idamycin (Idarubicin Hydrochloride) Idarubicin Hydrochloride Idelalisib Ifex ( ...
  7. Index to Drug-Specific Information (Food and Drug Administration)  
    ... hydrochlorothiazide) back to top I Ibandronate Ibuprofen Iclusig (ponatinib) Imatinib mesylate Iplex Incivek Infliximab Imitrex (sumatriptan) Innohep ( ... Placidyl (ethchlorvynol) Plan B (levonorgestrel) Plavix (clopidogrel ... (ezogabine) Pradaxa (dabigatran etexilate mesylate) Pramipexole Prasugrel ...
  8. ... chronic myelogenous leukemia. Imatinib mesylate , nilotinib , dasatinib , and ponatinib are tyrosine kinase inhibitors that are used to ...
  9. ... Gleevec ® ), dasatinib (Sprycel ® ), nilotinib (Tasigna ® ), bosutinib (Bosulif ® ), and ponatinib (Iclusig ® ). Although these drugs were originally aimed at ...
  10. Facts Spring 2014 (Leukemia & Lymphoma Society) - PDF  
    ... 60 days of completion of the last therapy. Ponatinib (Iclusig ® ) is approved to treat adult patients with ...
previous · 1 · 2 · next
Refine by Type